Adherence to antiretroviral therapy and drug resistance impact evolving viral suppression among a cohort of children and adolescents living with perinatal HIV infection in western Kenya

Rachel Vreeman, Winstone Nyandiko, Allison DeLong, Ashley Chory, Michael Scanlon, Josephine Aluoch, Edwin Sang, Vladimir Novitsky · 2026

Read Adherence to antiretroviral therapy and drug resistance impact evolving viral suppression among a cohort of children and adolescents living with perinatal HIV infection in western Kenya by Rachel Vreeman, Winstone Nyandiko, Allison DeLong, Ashley Chory, Michael Scanlon, Josephine Aluoch, Edwin Sang, Vladimir Novitsky (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0355492.txt.

Description

Rachel Vreeman led a team of eight authors studying children and teens born with HIV in western Kenya, published in PLOS ONE in 2026. These young people face a lifetime of antiretroviral treatment, and every missed dose invites drug resistance. The cohort study examined adherence and how resistance affects viral suppression as it evolves over time.

Vreeman's results guide pediatric HIV care strategies directly. Children depend on caregivers for doses, then take over as teens, a handover where adherence often slips. Knowing when suppression falters, and whether resistance is the cause, tells clinics where to add support. The western Kenya cohort offers evidence from a setting where perinatal HIV care is a daily reality, not a rarity.

Catalog record

CREATORRachel Vreeman, Winstone Nyandiko, Allison DeLong, Ashley Chory, Michael Scanlon, Josephine Aluoch, Edwin Sang, Vladimir Novitsky
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44100
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0355492

Browse the full library · About the Tower of Babel